Ipsos rolls out risk and reputation management platform
Ipsos rolls out risk and reputation management platform. From PR Week
Stay updated with breaking news from Strategic Evaluation. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Ipsos rolls out risk and reputation management platform. From PR Week
Teva Pharmaceutical Industries Ltd's (NYSE: TEVA) Q2 sales reached $3.88 billion, up 2% Y/Y (4% on constant currency), slightly beating the
Teva Pharmaceutical Industries Ltd (NYSE: TEVA) is reportedly considering potential strategic options for its active pharmaceutical ingredients (API) unit, which could include a potential sale. This news comes from individuals privy to the matter, who indicated that the current healthcare asset acquisitions continue despite the broader global slowdown in dealmaking. Working with consultants, Teva is attempting to identify potential buyers for its API unit, which could be valued at approximately
Investegate announcements from Cap10 Partners LLP, Recommended Cash Acquisition
/PRNewswire/ -- There's an old joke that goes: "Those who can, do; those who can't, teach." While this isn't true for most teachers, it seems to hold true for...